Optics

Avulux and Axon Optics have partnered to expand access to the latest light management lens technology for people with migraines, Avulux announced in a press release.

SAN DIEGO — Data from a 7-year clinical study of the MiSight 1-Day myopia control lens indicated that the fastest progressing eyes slowed the most during treatment, as reported at a virtual press conference held during Academy 2022.

LAS VEGAS — Scotland-based IbisVision, a developer of remote ophthalmic technology, plans to launch its IbisEngage and IbisConnect platforms in the U.S. by early 2023.

Research into concussions has been growing rapidly over the past decade. The majority of the research that has expanded our knowledge of the signs, symptoms and clinical course of youth concussion has focused on sport-related injuries.

NEW YORK – Clinicians should consider eye misalignment leading to trigeminal dysphoria in patients with symptoms of dry eye, fatigue, occipital and neck pain radiating to the eye, and light sensitivity, Ray Corbin-Simon, OD, said in a presentation at Vision Expo East.

NEW YORK – Luneau Technology Group announced at Vision Expo East that Visionix is its new global name.

NEW YORK – Amazon Echo created Echo Frames so eyeglass wearers could be connected to the world around them in a hands-free manner, company executives told Healio at Vision Expo East.

NEW ORLEANS – Orasis Pharmaceuticals has completed two phase 3 studies of its presbyopia candidate, CSF-1, CEO Elad Kedar said here at SECO 2022.

Topical latanoprostene bunod 0.024% significantly increased optic nerve head blood volume and oxygen saturation in healthy individuals compared with latanoprost, according to a study published in Optometry and Vision Science.

A bipartisan group of U.S. House of Representatives members wrote to the CDC asking about the agency’s efforts to encourage early detection and prevention of childhood myopia.